Physician

Arvind Y Krishna, MD

According to 2025 Medicare claims, Arvind Krishna, MD (NPI: 1275579542) practices endocrinology in the Canton-Massillon, OH market, with the plurality of this provider's patient population coming from Stark, OH. This provider's primary affiliated billing organization is DIABETES & ENDOCRINOLOGY ASSOCIATES OF STARK COUNTY INCORPORATED (NPI: 1003841669; TIN: 341049612) and primary practice location at 44718-2576. Krishna is affiliated with the IHC Quality Partners, LLC (ACO ID: A2833), participating under the MSSP model.

Krishna's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 787 traditional Medicare patients, billed 11,536 HCPCS/CPT codes, and received $152,682 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 4,034 prescription claims across 636 beneficiaries totaling $1,206,063 in drug costs, led by Somavert (Pegvisomant). DME data shows 318 claims. Open Payments data shows 86 records totaling $363,725. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $230,342 to $152,682. Concurrently, Part D prescription costs have changed little. For DME billing, reported payments rose steadily, from $24,585 to $65,504.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	940	18,010	$230,342
2016	1,004	16,908	$239,344
2017	992	20,821	$209,517
2018	960	24,333	$203,585
2019	904	22,525	$184,375
2020	807	20,476	$150,962
2021	822	27,540	$190,590
2022	817	19,598	$167,863
2023	784	16,795	$150,366
2024	787	11,536	$152,682

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	920	6,145	$1,225,381
2016	820	5,456	$1,162,864
2017	678	4,397	$1,102,787
2018	655	4,473	$1,276,041
2019	668	4,915	$1,461,620
2020	600	4,409	$1,239,761
2021	578	3,925	$1,162,444
2022	562	3,773	$1,321,131
2023	542	3,589	$1,262,374
2024	636	4,034	$1,206,063

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	417	872	$49,161
2016	402	865	$56,726
2017	297	608	$46,035
2018	288	643	$44,883
2019	228	690	$80,173
2020	177	535	$69,010
2021	115	462	$66,494
2022	88	407	$62,899
2023	64	356	$56,573
2024	92	318	$74,612

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	85	85	$102
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	545	1,431	$77
76536	Ultrasound scan of head and neck soft tissue	34	35	$65
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	268	441	$53
83036	Hemoglobin a1c level	113	153	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Somavert	Pegvisomant	13	390	$242,469
Jardiance	Empagliflozin	218	10,187	$199,461
Trulicity	Dulaglutide	90	3,248	$110,187
Ozempic	Semaglutide	72	2,245	$71,041
Tradjenta	Linagliptin	72	3,211	$52,501

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	31	113	$43,831
E0784	External ambulatory infusion pump, insulin	Y	N/R	21	$7,173
A4238	Supply allowance for adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	13	$6,534
J1817	Insulin for administration through dme (i.e., insulin pump) per 50 units	N	N/R	17	$5,349
A4224	Supplies for maintenance of insulin infusion catheter, per week	N	N/R	19	$4,811

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	36	$742	Corcept Therapeutics
Research Payments	Reported research-related payment or transfer-of-value amount.	50	$362,983	ABBVIE INC.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Arvind Y. Krishna, MD?

Tedicare shows public-source Medicare data for Arvind Y. Krishna, MD (NPI 1275579542), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Arvind Y. Krishna, MD have ACO affiliation data?

Arvind Y. Krishna, MD is shown with ACO affiliation data for IHC Quality Partners, LLC (MSSP, ACO ID A2833).

What billing organization is linked to Arvind Y. Krishna, MD?

Arvind Y. Krishna, MD is linked to DIABETES & ENDOCRINOLOGY ASSOCIATES OF STARK COUNTY INCORPORATED (billing NPI 1003841669) in the available physician profile data.

Does Arvind Y. Krishna, MD have Open Payments data?

Arvind Y. Krishna, MD has 86 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.